Human Liver Models Market – Emerging Industry Dynamics

Objectives of the Study:

To define, measure, and describe the global human liver model market by type and region

To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)

To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@

Factors Influencing Global Growth:-

The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure.

Issues Related to the Incorporation of Organoids Into Existing Workflows

Increasing Focus on Drug Discovery Activities
Rising Demand for Liver Transplantation
Growing Healthcare Market in the Asia Pacific and Latin America

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global human liver models market is expected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6% during the forecast period (2017-2022).

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@

Geographical Growth Scenario:

Geographic segments in this report include North America, Europe, Asia Pacific, and the RoW. Of these, the North American segment accounted for the largest share of the market in 2017. The human liver market for North America is driven by the presence of a well-established life sciences industry, growing awareness about the organoids technology, increasing government funding, growing incidence of NAFLD, and unavailability of livers for transplantation, increasing investments on research, rising focus on tissue culture-based clinical diagnostics, and the availability of skilled professionals.

Leading Market Players:

Emulate (US)
Ascendance Bio (US)
CN Bio (UK)
Organovo (US)
Cyfuse Biomedical (Japan) and many more…